Effect of home-based cardiac rehabilitation on health-related quality of life among older adults
Published
April 25, 2025
Paper ID
PAP-000212
Status
Published
DOI
10.65712/tmj.test000470
Advance Services
Abstract
Background: Practice around home-based cardiac rehabilitation varies widely between centres. Methods: Missing data were handled with multiple imputation. Results: health-related quality of life occurred in 18% of the intervention group versus 37% of controls. Effects were consistent across prespecified subgroups. Conclusion: Future work should test home-based cardiac rehabilitation in a pragmatic multicentre trial.
Introduction
The cost of health-related quality of life to health systems is substantial. health-related quality of life remains a leading cause of avoidable harm among older adults.
The cost of health-related quality of life to health systems is substantial. Practice around home-based cardiac rehabilitation varies widely between centres. Guidelines make only a weak recommendation on home-based cardiac rehabilitation.
Discussion
Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.
These findings suggest that home-based cardiac rehabilitation is associated with better health-related quality of life in older adults. Future work should test home-based cardiac rehabilitation in a pragmatic multicentre trial.
Conclusions
Home-based cardiac rehabilitation should be considered for older adults to improve health-related quality of life.
References
1. Lindqvist A, Schmidt N, et al. Machine-learning triage and in-hospital mortality. BMJ. 2008;341(10):766-1491.
2. Novak Z, Andersen O, et al. Nurse-led discharge planning and emergency department revisits. BMC Med. 2022;329(5):679-1159.
3. Okafor U, Larsen P, et al. Telemedicine follow-up and length of stay. Diabetes Care. 2015;325(1):139-1649.
4. Dubois U, Mueller R, et al. Low-dose aspirin and health-related quality of life. Pediatrics. 2012;26(1):94-1275.
5. Okafor N, Schmidt W, et al. Early mobilisation and falls. Pediatrics. 2016;165(1):178-1450.
6. Rahman O, Mueller O, et al. An enhanced recovery pathway and post-operative delirium. Pediatrics. 2013;88(10):314-1477.
7. Andersen D, Okafor V, et al. An enhanced recovery pathway and health-related quality of life. BMJ. 2013;244(2):744-1035.
8. Farouk T, Kaur Y, et al. Continuous glucose monitoring and length of stay. Eur Heart J. 2025;310(1):128-1737.
9. Nakamura G, Rahman Q, et al. Pharmacist-led medication review and surgical site infection. Ann Intern Med. 2022;147(3):587-1490.
Appendices
The statistical analysis plan is in the online supplement.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. We conducted a multicentre observational study across 4 centres between 2016 and 2022. The primary outcome was health-related quality of life, assessed blind to allocation.
We conducted a multicentre observational study across 7 centres between 2014 and 2021. The primary outcome was health-related quality of life, assessed blind to allocation. Missing data were handled with multiple imputation. We conducted a multicentre observational study across 2 centres between 2015 and 2024.
We conducted a multicentre observational study across 13 centres between 2018 and 2022. We conducted a multicentre observational study across 12 centres between 2020 and 2025. Eligible participants were older adults.
Results
680 participants were included (median age 70 years). Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.85 (95% CI 0.41 to 0.61).
| Group | n | Events |
|---|---|---|
| Age ≥ 65 | 575 | 69 |
| Centre A | 359 | 8 |
| Intervention | 57 | 110 |
| Control | 210 | 64 |
Values are n (%) unless stated otherwise.

Shown for older adults; error bars are 95% confidence intervals.

Shown for older adults; error bars are 95% confidence intervals.
Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.70 (95% CI 0.22 to 0.79).
171 participants were included (median age 77 years). Serious adverse events were rare and similar between groups.